We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
-$10.9M
Cap. Flow
+$479K
Cap. Flow %
0.72%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$1.07M

Top Sells

Rank Stock Value
1
TYRA icon
Tyra Biosciences
TYRA
+$456K
2
RLYB icon
Rallybio
RLYB
+$130K

Sector Composition

Rank Sector Weight
1 Healthcare 59.6%
2 Technology 40.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
1
Tyra Biosciences
TYRA
$1.9B
$38.5M 58.09%
4,144,590
-35,267
-0.8% -$456K
AEVA
2
Aeva Technologies
AEVA
$1.2B
$25.9M 39%
3,697,039
– –
RLYB icon
3
Rallybio
RLYB
$84.5M
$1M 1.51%
191,569
-20,642
-10% -$130K
UPBD icon
4
Upbound Group
UPBD
$1.13B
$930K 1.4%
+38,824
New +$1.07M

Similar funds

CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
MF
Midwestern Financial Iowa City, Iowa $127M AUM 13.96% 1-Year Est. Return
SAP
Strategic Advisory Partners Greensboro, North Carolina $127M AUM
S
Storgate Dallas, Texas $127M AUM
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
VDC
Van Diest Capital Poly City, Iowa $127M AUM
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return

Canaan Partners XI's Q1 2025 Portfolio in Review

As of Q1 2025, Canaan Partners XI held 4 positions worth $66.4M, down 14% from $77.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners XI's Q1 2025 filing shows 1 new and 2 reduced positions. Its largest new stake was Upbound Group: 38,824 shares worth $930K. The largest sale was Tyra Biosciences, an estimated $456K.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 77% a quarter earlier, followed by Technology.

  • Canaan Partners XI's largest Q1 2025 buy was Upbound Group: 38,824 shares worth $930K.
  • Canaan Partners XI's biggest Q1 2025 reduction was Tyra Biosciences, cutting an estimated $456K.
  • Canaan Partners XI's ten largest holdings make up 100% of its $66.4M portfolio in Q1 2025.
  • Canaan Partners XI opened 1 new position and closed 0 in Q1 2025.
  • Canaan Partners XI's portfolio value fell 14% quarter-over-quarter to $66.4M.

Based on Canaan Partners XI's 13F filing for Q1 2025, filed 9 Apr 2025.